Bronchial Diseases: Clinical Trials

51 trials for Bronchial Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 terminated. 51 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 451Terminated 51

Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases

Trials (filtered) newest first · largest first

All 51 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA
Administration via pressurized metered dose inhaler (pMDI) - Asthma
Phase 4TerminatedChiesi Farmaceutici S.p.A.3202022-02-252024-11-15
Steroid Use in Non-RSV Bronchiolitis
Placebos, Dexamethasone Oral - Bronchiolitis, Viral
Phase 4TerminatedAllison Williams32020-02-032023-03-21
Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
Aztreonam lysine, Placebo - Bronchiectasis Adult
Phase 4TerminatedUniversity of Dundee342019-10-192026-01-12
Avoiding Neuromuscular Blockers to Reduce Complications
Neuromuscular Blocking Agents, Anesthetic Adjuncts - Respiratory Failure, Respiratory Infection
Phase 4TerminatedBeth Israel Deaconess Medical Center32019-08-072026-06-04
The Effect of NAC on Lung Function and CT Mucus Score
n-acetylcystine + albuterol, 0.9% saline + albuterol - Asthma
Phase 4TerminatedUniversity of California, San Francisco42019-02-202026-06-11
Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup
Dexamethasone IV for PO, Dexamethasone crushed tablets - Asthma, Croup
Phase 4TerminatedVanderbilt University Medical Center402018-10-232021-11-08
Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
Albuterol Sulfate, Interval Warm-up exercise - Asthma in Children, Obesity, Childhood
Phase 4TerminatedUniversity of Nevada, Las Vegas342018-09-182021-07-22
Comparison of Albuterol for Status Asthmaticus
preservative free albuterol - Status Asthmaticus
Phase 4TerminatedNorton Healthcare82018-09-102021-05-20
Inpatient Clinical Trial of NAC
N-acetylcysteine - Asthma
Phase 4TerminatedUniversity of California, San Francisco12018-07-062021-10-26
Targeted AntiBiotics for Chronic Pulmonary Diseases
Piperacillin/tazobactam, Ciprofloxacin - COPD, Respiratory Tract Infections
Phase 4TerminatedChronic Obstructive Pulmonary Disease Trial Network, Denmark512018-01-102023-05-25
PRISTINE - Personalised Approach to Improve aSThma prescrIbing iN childrEn
Montelukast or Salmeterol or Theophylline or Steroid - Asthma
Phase 4TerminatedBrighton and Sussex University Hospitals NHS Trust22017-07-012019-12-18
An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation
Reslizumab, Fludeoxyglucose F 18 (FDG), Placebo - Asthma
Phase 4TerminatedTeva Branded Pharmaceutical Products R&D, Inc.52017-05-082021-11-09
Steroids in Children Hospitalized With Asthma
Dexamethasone, Prednisone - Asthma, Status Asthmaticus
Phase 4TerminatedUniversity of Florida62017-03-202019-06-21
Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis
Azelastine-Fluticasone Nasal, Placebos - Asthma, Allergic, Rhinitis,Allergic
Phase 4TerminatedUniversity of Dundee72017-01-202019-04-08
High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis
Oxygen - Bronchiolitis
Phase 4TerminatedIRCCS Burlo Garofolo302017-01-012020-09-04
C1-inhibitor in Allergic ASThma Patients
C1-inhibitor, Saline, Antibiotics - Asthma
Phase 4TerminatedT. van der Poll372016-11-162020-06-24
Efficacy of Intermittent Tiotropium in Early Childhood Wheezing
Tiotropium Bromide, Fluticasone Propionate, Salbutamol - Wheezy Bronchitis, Asthmatic Bronchitis
Phase 4TerminatedHelsinki University Central Hospital802016-04-202024-09-19
Effect of Losartan on Airway Mucociliary Dysfunction in Patients With COPD and Chronic Bronchitis
Losartan 50 mg, Losartan 100 mg - COPD, Chronic Bronchitis
Phase 4TerminatedUniversity of Miami312016-03-312020-08-20
Clinical Trial of NAC in Asthma
n-acetylcystine, 0.9% saline - Asthma
Phase 4TerminatedUniversity of California, San Francisco12016-03-012019-08-20
Sputum-derived Cellular Targets After Xolair (Omalizumab)
Omalizumab, Placebo - Asthma
Phase 4TerminatedNYU Langone Health32016-01-012019-09-30

Showing 20 of 51. Sign in to see all of them.

Narrower conditions

Asthma (35)  ·  Bronchitis, Chronic (5)  ·  Pulmonary Disease, Chronic Obstructive (5)  ·  Bronchiolitis Obliterans Syndrome (4)  ·  Bronchiolitis (3)  ·  Respiratory Tract Infections (3)  ·  Asthma, Exercise-Induced (2)  ·  Bronchiectasis (2)  ·  Dyspnea (2)  ·  Emphysema (2)  ·  Pneumonia (2)  ·  Respiratory Sounds (2)  ·  Status Asthmaticus (2)  ·  Airway Obstruction (1)  ·  Albuminuria (1)

Broader conditions

Respiratory Tract Diseases (50)  ·  Lung Diseases (47)  ·  Lung Diseases, Obstructive (47)  ·  Immune System Diseases (41)  ·  Hypersensitivity, Immediate (37)  ·  Respiratory Hypersensitivity (37)  ·  Hypersensitivity (36)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Bronchitis (12)  ·  Infections (11)  ·  Pathologic Processes (11)  ·  Chronic Disease (10)  ·  Disease Attributes (10)  ·  Respiratory Tract Infections (8)

Interventions

Albuterol (5)  ·  Fluticasone (5)  ·  Fluticasone-Salmeterol Drug Combination (4)  ·  Acetylcysteine (3)  ·  Adrenal Cortex Hormones (3)  ·  Azithromycin (3)  ·  Budesonide (3)  ·  Calcium Dobesilate (3)  ·  Dexamethasone (3)  ·  Mometasone Furoate (3)  ·  Sodium Chloride (3)  ·  montelukast (3)  ·  Ciprofloxacin (2)  ·  Formoterol Fumarate (2)  ·  Methylprednisolone (2)

Sponsors

University of California, San Francisco (3)  ·  GlaxoSmithKline (2)  ·  Novartis Pharmaceuticals (2)  ·  Organon and Co (2)  ·  Sanofi (2)  ·  Teva Branded Pharmaceutical Products R&D, Inc. (2)  ·  University of Alberta (2)  ·  University of Dundee (2)  ·  Allison Williams (1)  ·  Apieron (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Boehringer Ingelheim (1)  ·  Boston Children's Hospital (1)  ·  Brighton and Sussex University Hospitals NHS Trust (1)  ·  Chiesi Farmaceutici S.p.A. (1)

Countries

United States (32)  ·  Canada (4)  ·  United Kingdom (4)  ·  Germany (2)  ·  Italy (2)  ·  Spain (2)  ·  Austria (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)

Top investigators

Irvin Mayers, MD, FRCPC (2)  ·  John Fahy, M.D, M.Sc. (2)  ·  Allison E Williams, MD (1)  ·  Alyssa H Silver, MD (1)  ·  Benjamin Natelson, MD (1)  ·  Brian Lipworth, MD (1)  ·  Chrsitopher Compton (1)  ·  Cornelis Wortel, MD, PhD (1)  ·  Dharini M Bhammar, Ph.D. (1)  ·  Diana S. Lee, MD (1)  ·  Donald Arnold, MD, MPH (1)  ·  Edibe Taylan (1)  ·  Egidio Barbi, MD (1)  ·  Eric C Kleerup, MD (1)

Results publications

PMID 18951618, PMID 24267370, PMID 26598458, PMID 27560168, PMID 31238116, PMID 32572189, PMID 34303860, PMID 35124256, PMID 35235189, PMID 35942814, PMID 36596609, PMID 38007586, PMID 38484432, PMID 38844921, PMID 39164407

NIH funding

2015 (2), 2014 (1), 2018 (1), P01HL128191 (1), R01HL133240 (1), R01HL139365 (1), R01NS057594 (1), U10HL064287 (1), U10HL064288 (1), U10HL064295 (1), U10HL064305 (1), U10HL064307 (1), U10HL064313 (1)